SCHEMBL4556708

SCHEMBL4556708

OB(OOc1cccc(F)c1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
ENPP2 Q13822 2/20 0.40
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MGLL Q99685 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
PGR P06401 1/20 0.35
SLC6A4 P31645 2/20 0.35
ATM Q13315 1/20 0.35
NFE2L2 Q16236 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13857958 0.86 TRPV6 (0.35) ENPP2CA1CA2MGLLCA4
SCHEMBL624916 0.82 TRPV6 (0.44) ENPP2CA1CA2MGLLCA4
SCHEMBL18587216 0.73 IDO1 (0.47) NR4A2LMNA
SCHEMBL22500900 0.70 ENPP2 (0.43) ENPP2CA1CA2MGLLMEN1
SCHEMBL3658498 0.70 IDO1 (0.40) PPARGPPARAENPP2MGLLCA4
SCHEMBL31395446 0.69 PPARG (0.40) PPARGPPARAENPP2HPGDSLC6A4
SCHEMBL1828620 0.69 PPARG (0.40) PPARGPPARAENPP2HPGDSLC6A4
SCHEMBL29428818 0.68 LTA4H (0.57) PPARGPPARACA1CA2MEN1
SCHEMBL8416223 0.68 LTA4H (0.57) PPARGPPARACA1CA2MEN1
SCHEMBL28194677 0.67 PPARG (0.39) PPARGPPARAENPP2HPGDSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8629125-B2 Inhibitors of fatty acid amide hydrolase Infinty Pharmaceuticals, Inc. (US) 2014-01-14 US disclosed
US-20130059819-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
EP-2073816-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE Infinity Pharmaceuticals, Inc. (US) 2009-07-01 EP disclosed
WO-2008063300-A2 BORONIC ACIDS AND ESTERS AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059819-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 PPARG 567/4885PPARA 633/4885ENPP2 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.